Actylis announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d'Urfe site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis' WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations. The new system's strategic location in Montreal positions it as a pivotal hub for biopharmaceutical companies across North America and beyond.

Its proximity to major transportation networks ensures timely distribution of WFI to manufacturers, enabling them to streamline their production processes and meet growing market demands.